Close
Close

Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)

Access Programs

Disease Information

Descriptive Information
Brief Title † Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)
Official Title † Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)
Brief Summary The aim of the cohort study SCAN (Screening Cardiovascular patients for Aortic aNeurysms) is to establish a screening programm for patients with a high risk for an AAA. Aortic aneurysms in these patients should be identified at an early stage and thereby AAA-associated mortality be decreased.
Detailed Description A recently published meta-analysis showed a higher prevalence of aortic aneurysm (AAA) in men requiring treatment of coronary heart disaese compared to standard population. In women, however, the prevalence was not increased. Thus, the SCAN project addresses male patients who underwent coronary artery intervention in order to screen them for the presence of an AAA using duplex sonography. The SCAN project involves the following elements: 1. Informing the patient with cardiovascular risk factors about the clinical picture of AAA 2. An ultrasound scan of the abdominal aorta in patients with an increased risk for AAA 3. Acquisition of patient data followed by a correlation analysis for the parameters presence of AAA and cardiovascular diseases The cohort study is part of the SCAN project which is also conducted in an similar way by Catharina Ziekenhuis Eindhoven ClinicalTrials.gov Identifier:NCT01643317.
Study Phase N/A
Study Type † Observational
Study Design † Observational Model: Cohort, Time Perspective: Prospective
Primary Outcome Measure † Prevalence of AAA
Secondary Outcome Measure † Prevalence of AAA in the cohort requiring treatment
Condition † Abdominal Aortic Aneurysm AAA
Intervention †
Study Arms / Comparison Groups
Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status †
Estimated Enrollment † 1000
Start Date † March 2014
Completion Date April 2018
Primary Completion Date December 2017
Eligibility Criteria † Inclusion Criteria: - men with coronary artery intervention (PTCA/stenting) - at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history) Exclusion Criteria: - life expectancy less than 1 year - inability to follow the instructions of the investigator (dementia, lack of time, insufficient understanding of the language) - insufficient compliance
Gender Male
Ages N/A - N/A
Accepts Healthy Volunteers No
Contacts †† Hans-Henning Eckstein, Univ.-Prof.Dr.med., 0049894140, gefaesschirurgie@lrz.tum.de
Location Countries † Germany
Administrative Information
NCT ID † NCT02179801
Organization ID GES_SCAN
Secondary IDs ††
Responsible Party Principal Investigator
Study Sponsor † Technische Universität München
Collaborators †† I. Medizinischen Klinik und Poliklinik, Technical University of Munich
Investigators † Principal Investigator: Hans-Henning Eckstein, Univ.-Prof.Dr.med., Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar der Technische Universität München
Information Provided By
Verification Date January 2017
First Received Date † June 12, 2014
Last Updated Date January 5, 2017
† Required WHO trial registration data element.
†† WHO trial registration data element that is required only if it exists.
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
28,851 views
by Christine DuBois
23,379 views
by Abidemi Uruejoma
21,241 views
Free Newsletter